Ratings by Maxim Group (Jason McCarthy)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/17/2022 | Femasys Inc. | FEMY | New Coverage | Buy (N/A) |
1.30 (2.01) |
54.62% | Details | |
| 6/17/2022 | ABVC BioPharma, Inc. | ABVC | New Coverage | Buy (N/A) |
0.96 (1.01) |
5.21% | Details | |
| 6/15/2022 | Biocept | BIOC | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2022 | Vertex | VRTX | Upgrade | Buy (Hold) |
268.65 (287.32) |
6.95% | Details | |
| 5/26/2022 | Titan Pharmaceuticals | TTNP | Downgrade | Hold (Buy) |
0.38 (0.53) |
39.47% | Details | |
| 5/12/2022 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2022 | Synaptogenix, Inc. | SNPX | New Coverage | Buy (N/A) |
7.03 (5.16) |
-26.6% | Details | |
| 3/16/2022 | Unicycive Therapeutics | UNCY | New Coverage | Buy (N/A) |
1.07 (0.82) |
-23.36% | Details | |
| 1/19/2022 | INVO Bioscience Inc. | INVO | New Coverage | Buy (N/A) |
3.69 (0.78) |
-78.86% | Details | |
| 11/30/2021 | Citius Pharmaceuticals | CTXR | New Coverage | Buy (N/A) |
1.62 (0.89) |
-45.06% | Details | |
| 11/30/2021 | atai Life Sciences N.V | ATAI | New Coverage | Buy (N/A) |
10.98 (3.65) |
-66.76% | Details | |
| 11/29/2021 | Acurx Pharmaceuticals inc. | ACXP | New Coverage | Buy (N/A) |
4.89 (3.75) |
-23.31% | Details | |
| 11/19/2021 | Cybin Inc. | CYBN | Downgrade | Hold (Buy) |
1.64 (0.56) |
-65.85% | Details | |
| 11/15/2021 | Appili Therapeutics Inc. | APLI | Downgrade | Hold (Buy) |
0.00 (0.00) |
0% | Details | |
| 10/29/2021 | Protagenic Therapeutics, Inc | PTIX | New Coverage | Buy (N/A) |
1.80 (0.69) |
-61.67% | Details | |
| 10/19/2021 | Indaptus Therapeutics | INDP | Upgrade | Buy (Hold) |
7.54 (3.13) |
-58.49% | Details | |
| 10/6/2021 | BioTime, Inc. | BTX | New Coverage | Buy (N/A) |
9.01 (0.54) |
-94.01% | Details | |
| 10/6/2021 | RenovoRx Inc. | RNXT | New Coverage | (N/A) |
5.72 (2.00) |
-65.03% | Details | |
| 10/4/2021 | GeoVax Labs Inc. | GOVX | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2021 | Omeros Corp. | OMER | Downgrade | Hold (Buy) |
8.54 (4.64) |
-45.67% | Details | |
| 10/1/2021 | Omeros Corp. | OMER | Downgrade | Hold (Buy) |
13.79 (4.64) |
-66.35% | Details | |
| 8/11/2021 | CohBar | CWBR | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2021 | Reviva Pharmaceuticals | RVPH | New Coverage | Buy (N/A) |
3.83 (1.20) |
-68.67% | Details | |
| 7/1/2021 | Stealth BioTherapeutics | MITO | New Coverage | Buy (N/A) |
1.56 (0.25) |
-83.97% | Details | |
| 6/29/2021 | DiaMedica Therapeutics Inc. | DMAC | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Enveric Biosciences | ENVB | New Coverage | Buy (N/A) |
2.17 (0.21) |
-90.32% | Details | |
| 6/28/2021 | Compass Pathways | CMPS | New Coverage | Buy (N/A) |
33.49 (10.80) |
-67.75% | Details | |
| 6/28/2021 | MindMed | MNMD | New Coverage | Buy (N/A) |
3.72 (0.58) |
-84.41% | Details | |
| 6/24/2021 | SELLAS Life Sciences Group | SLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2021 | Atossa Genetics | ATOS | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2021 | Clene, Inc. | CLNN | New Coverage | Buy (N/A) |
8.95 (2.54) |
-71.62% | Details | |
| 5/13/2021 | Galmed Pharmaceuticals | GLMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2021 | Avanos Medical | AVNS | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2021 | BioLineRx | BLRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2021 | CohBar | CWBR | New Coverage | Buy (N/A) |
1.24 (0.21) |
-83.06% | Details | |
| 4/19/2021 | Fennec Pharmaceuticals Inc. | FENC | New Coverage | Buy (N/A) |
6.27 (5.71) |
-8.93% | Details | |
| 4/7/2021 | Mesoblast Limited | MESO | Upgrade | Buy (Hold) |
8.45 (2.45) |
-71.01% | Details | |
| 3/31/2021 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2021 | Amryt | AMYT | New Coverage | Buy (N/A) |
13.84 (7.06) |
-48.99% | Details | |
| 3/29/2021 | Co-Diagnostics | CODX | Downgrade | Hold (Buy) |
9.70 (5.84) |
-39.79% | Details | |
| 3/25/2021 | OncoSec Medical | ONCS | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2021 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2021 | Synthetic Biologics | SYN | Upgrade | Buy (Hold) |
0.92 (0.23) |
-75% | Details | |
| 3/12/2021 | Synthetic Biologics | SYN | Upgrade | Buy (Hold) |
0.71 (0.23) |
-67.61% | Details | |
| 3/12/2021 | TFF Parmaceuticals | TFFP | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2021 | Entera Bio | ENTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2021 | Panbella Therapeutics | PBLA | New Coverage | Buy (N/A) |
4.17 (0.74) |
-82.25% | Details | |
| 3/10/2021 | MediciNova | MNOV | New Coverage | Buy (N/A) |
5.68 (2.47) |
-56.51% | Details | |
| 2/18/2021 | Titan Pharmaceuticals | TTNP | Upgrade | Buy (Hold) |
3.55 (0.53) |
-85.07% | Details | |
| 2/17/2021 | Artelo Biosciences Inc | ARTL | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Cassava Sciences | SAVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2021 | Cyclo Therapeutics | CYTH | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2021 | Lineage Cell Therapeutics Inc. | LCTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2021 | Brainstorm Cell Therapeutics | BCLI | Upgrade | Buy (Hold) |
6.17 (2.75) |
-55.43% | Details | |
| 1/25/2021 | Kintara Therapeutics, Inc | KTRA | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2021 | INmune Bio Inc. | INMB | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2021 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2021 | Bionano Genomics | BNGO | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2021 | Cellectar Biosciences | CLRB | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2021 | Cellectar Biosciences | CLRB | Maintain | Hold (N/A) |
|
Details | ||
| 1/7/2021 | Artelo Biosciences, Inc. | ARTL | Upgrade | Buy (Hold) |
0.89 (0.31) |
-65.17% | Details | |
| 12/23/2020 | Soligenix | SNGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2020 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2020 | SELLAS Life Sciences Group | SLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2020 | Mesoblast Limited | MESO | Downgrade | Hold (Buy) |
8.59 (8.45) |
-1.63% | Details | |
| 12/10/2020 | CNS Pharmasceuticals Inc. | CNSP | New Coverage | Buy (N/A) |
2.58 (0.27) |
-89.53% | Details | |
| 12/9/2020 | bluebird bio | BLUE | Downgrade | Hold (Buy) |
44.40 (4.28) |
-90.36% | Details | |
| 11/19/2020 | Galapagos NV | GLPG | New Coverage | Buy (N/A) |
123.95 (56.69) |
-54.26% | Details | |
| 11/16/2020 | Adamis Pharmaceuticals | ADMP | Downgrade | Hold (Buy) |
0.68 (0.50) |
-26.47% | Details | |
| 11/6/2020 | BeiGene, Ltd. | BGNE | Downgrade | Hold (Buy) |
300.00 (166.95) |
-44.35% | Details | |
| 10/30/2020 | 9 Meter Biopharma | NMTR | New Coverage | (N/A) |
0.68 (0.22) |
-67.65% | Details | |
| 10/16/2020 | Plus Therapeutics Inc. | PSTV | New Coverage | Buy (N/A) |
2.56 (0.54) |
-78.91% | Details | |
| 10/5/2020 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 10/5/2020 | Synthetic Biologics | SYN | Downgrade | Hold (Buy) |
0.46 (0.71) |
54.35% | Details | |
| 10/2/2020 | Synthetic Biologics | SYN | Downgrade | Hold (Buy) |
0.46 (0.23) |
-50% | Details | |
| 9/28/2020 | Inovio Pharmaceuticals | INO | Upgrade | Buy (Hold) |
16.94 (1.89) |
-88.84% | Details | |
| 9/15/2020 | Gilead Sciences | GILD | Upgrade | Buy (Hold) |
66.34 (62.36) |
-6% | Details | |
| 9/14/2020 | Cassava Sciences | SAVA | Upgrade | Buy (Hold) |
3.32 (26.51) |
698.49% | Details | |
| 8/24/2020 | Onconova Therapeutics | ONTX | Downgrade | Hold (Buy) |
1.01 (1.30) |
28.71% | Details | |
| 8/17/2020 | Titan Pharmaceuticals | TTNP | Downgrade | Hold (Buy) |
0.28 (0.53) |
89.29% | Details | |
| 8/14/2020 | Titan Pharmaceuticals | TTNP | Downgrade | Hold (Buy) |
0.30 (0.53) |
76.67% | Details | |
| 7/30/2020 | Onconova Therapeutics | ONTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2020 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2020 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2020 | Atossa Genetics | ATOS | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2020 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2020 | TFF Parmaceuticals | TFFP | New Coverage | Buy (N/A) |
6.22 (5.76) |
-7.4% | Details | |
| 7/8/2020 | DiaMedica Therapeutics Inc. | DMAC | New Coverage | Buy (N/A) |
6.75 (2.07) |
-69.33% | Details | |
| 7/1/2020 | Inovio Pharmaceuticals | INO | Downgrade | Hold (Buy) |
26.95 (16.94) |
-37.14% | Details | |
| 6/23/2020 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2020 | Bionano Genomics | BNGO | Maintain | Buy (N/A) |
|
Details | ||
| 5/21/2020 | Precipio | PRPO | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2020 | Co-Diagnostics | CODX | Upgrade | Buy (Hold) |
18.85 (5.84) |
-69.02% | Details | |
| 5/15/2020 | Cassava Sciences | SAVA | Downgrade | Hold (Buy) |
8.11 (3.32) |
-59.06% | Details | |
| 5/15/2020 | Onconova Therapeutics | ONTX | Upgrade | Buy (Hold) |
0.36 (1.01) |
180.56% | Details | |
| 5/13/2020 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | Adamis Pharmaceuticals | ADMP | Upgrade | Buy (Hold) |
0.52 (0.68) |
30.77% | Details | |
| 5/12/2020 | Appolo Therapeutics | APLI | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2020 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2020 | Interpace Diagnostics Group Inc | IDXG | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2020 | Immutep Limited | IMMP | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2020 | AIM ImmunoTech | AIM | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2020 | Appili Therapeutics Inc. | APLI | New Coverage | Buy (N/A) |
0.00 (0.00) |
0% | Details | |
| 3/10/2020 | Cidara Therapeutics | CDTX | New Coverage | Buy (N/A) |
2.65 (0.45) |
-83.02% | Details | |
| 3/6/2020 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2020 | Heat Biologics | HTBX | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | Co-Diagnostics | CODX | Downgrade | Hold (Buy) |
17.81 (5.84) |
-67.21% | Details | |
| 2/24/2020 | ContraFect Corp. | CFRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2020 | Aptose Biosciences | APTO | New Coverage | Buy (N/A) |
8.60 (0.80) |
-90.7% | Details | |
| 2/18/2020 | OncoSec Medical | ONCS | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Navidea Biopharmaceuticals | NAVB | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Co-Diagnostics | CODX | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2020 | Heat Biologics | HTBX | New Coverage | Buy (N/A) |
0.26 (2.83) |
988.46% | Details | |
| 2/3/2020 | Capricor Therapeutics | CAPR | Upgrade | Buy (Hold) |
1.53 (3.68) |
140.52% | Details | |
| 1/8/2020 | Xenetic Biosciences | XBIO | New Coverage | Buy (N/A) |
1.47 (0.76) |
-48.3% | Details | |
| 12/18/2019 | Atossa Genetics | ATOS | Upgrade | Buy (Hold) |
1.42 (1.01) |
-28.87% | Details | |
| 11/26/2019 | Onconova Therapeutics | ONTX | Downgrade | Hold (Buy) |
0.14 (0.36) |
157.14% | Details | |
| 11/25/2019 | Adamis Pharmaceuticals | ADMP | Downgrade | Hold (Buy) |
1.26 (0.50) |
-60.32% | Details | |
| 11/22/2019 | Precipio | PRPO | New Coverage | Buy (N/A) |
2.02 (1.11) |
-45.05% | Details | |
| 11/15/2019 | SELLAS Life Sciences Group | SLS | Upgrade | Buy (Hold) |
6.17 (2.20) |
-64.34% | Details | |
| 11/7/2019 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2019 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2019 | Gilead Sciences | GILD | Downgrade | Hold (Buy) |
66.00 (62.36) |
-5.52% | Details | |
| 10/23/2019 | Titan Pharmaceuticals | TTNP | Upgrade | Buy (Hold) |
0.19 (0.30) |
57.89% | Details | |
| 10/10/2019 | BioCardiAa | BCDA | New Coverage | Buy (N/A) |
3.36 (1.46) |
-56.55% | Details | |
| 10/10/2019 | AIM ImmunoTech | AIM | Upgrade | Buy (Hold) |
0.57 (0.78) |
36.84% | Details | |
| 9/25/2019 | AzurRx Biopharma | AZRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2019 | Neurotrope | NTRP | Downgrade | Hold (Buy) |
4.40 (0.94) |
-78.64% | Details | |
| 9/6/2019 | Del Mar Pharma | DMPI | New Coverage | Buy (N/A) |
0.61 (1.34) |
119.67% | Details | |
| 8/22/2019 | Hemispherx | HEB | Downgrade | Hold (Buy) |
1.92 (1.80) |
-6.25% | Details | |
| 8/15/2019 | Titan Pharmaceuticals | TTNP | Downgrade | Hold (Buy) |
0.70 (0.19) |
-72.86% | Details | |
| 8/15/2019 | Abeona Therapeutics | ABEO | Downgrade | Hold (Buy) |
2.43 (0.19) |
-92.18% | Details | |
| 8/6/2019 | Hancock Jaffe Laboratories | HJLI | New Coverage | Buy (N/A) |
1.13 (10.38) |
818.58% | Details | |
| 8/2/2019 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | TrovaGene | TROV | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | OncoSec Medical | ONCS | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | Immutep Limited | IMMP | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | Entera Bio | ENTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2019 | Bionano Genomics | BNGO | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2019 | Intec Pharma Ltd. | NTEC | Downgrade | Hold (Buy) |
2.99 (9.63) |
222.07% | Details | |
| 7/9/2019 | ARTL | New Coverage | Buy (N/A) |
4.15 (0.31) |
-92.53% | Details | ||
| 6/27/2019 | Atossa Genetics | ATOS | Downgrade | Hold (Buy) |
2.23 (1.42) |
-36.32% | Details | |
| 6/26/2019 | Titan Pharmaceuticals | TTNP | New Coverage | Buy (N/A) |
1.40 (0.70) |
-50% | Details | |
| 6/25/2019 | Cassava Sciences | SAVA | New Coverage | Buy (N/A) |
1.24 (8.11) |
554.03% | Details | |
| 6/18/2019 | bluebird bio | BLUE | Upgrade | Buy (Hold) |
117.66 (4.28) |
-96.36% | Details | |
| 6/14/2019 | Hemispherx | HEB | New Coverage | Buy (N/A) |
5.35 (1.92) |
-64.11% | Details | |
| 6/14/2019 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
2.65 (4.91) |
85.28% | Details | |
| 6/11/2019 | ContraFect Corp. | CFRX | New Coverage | Buy (N/A) |
0.42 (3.10) |
638.1% | Details | |
| 5/3/2019 | ContraFect Corp. | CFRX | New Coverage | Buy (N/A) |
0.56 (0.42) |
-25% | Details | |
| 4/30/2019 | BeyondSpring Inc. | BYSI | Downgrade | Hold (Buy) |
15.54 (1.56) |
-89.96% | Details | |
| 4/9/2019 | Co-Diagnostics | CODX | New Coverage | Buy (N/A) |
1.07 (17.81) |
1564.49% | Details | |
| 4/3/2019 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2019 | VolitionRX | VNRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2019 | Proteon Therapeutics | PRTO | Downgrade | Hold (Buy) |
3.48 (0.84) |
-75.86% | Details | |
| 3/27/2019 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2019 | Atossa Genetics | ATOS | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2019 | Biocept | BIOC | New Coverage | Buy (N/A) |
1.03 (0.94) |
-8.74% | Details | |
| 3/22/2019 | SELLAS Life Sciences Group | SLS | Downgrade | Hold (Buy) |
1.31 (6.17) |
370.99% | Details | |
| 3/20/2019 | ContraVir Pharma | CTRV | Downgrade | Hold (Buy) |
0.31 (3.58) |
1054.84% | Details | |
| 3/19/2019 | Moleculin Biotech | MBRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2019 | INmune Bio Inc. | INMB | New Coverage | Buy (N/A) |
7.08 (8.77) |
23.87% | Details | |
| 3/18/2019 | AzurRx Biopharma | AZRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2019 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2019 | Proteon Therapeutics | PRTO | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2019 | Mesoblast Limited | MESO | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2019 | AzurRx Biopharma | AZRX | New Coverage | Buy (N/A) |
1.81 (3.45) |
90.61% | Details | |
| 2/6/2019 | Vertex | VRTX | Downgrade | Hold (Buy) |
187.02 (287.32) |
53.63% | Details | |
| 1/24/2019 | BioTime, Inc. | BTX | New Coverage | Buy (N/A) |
0.94 (0.54) |
-42.55% | Details | |
| 1/3/2019 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2018 | Capricor Therapeutics | CAPR | Downgrade | Hold (Buy) |
0.45 (1.53) |
240% | Details | |
| 12/13/2018 | Adial Pharmaceuticals Inc | ADIL | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2018 | Moleculin Biotech | MBRX | New Coverage | Buy (N/A) |
1.31 (1.47) |
12.21% | Details | |
| 11/12/2018 | Matinas BioPharma Holdings Inc. | MTNB | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2018 | IsoRay, Inc. | ISR | Downgrade | Hold (Buy) |
0.48 (0.29) |
-39.58% | Details | |
| 10/30/2018 | Adial Pharmaceuticals Inc | ADIL | New Coverage | Buy (N/A) |
1.95 (1.20) |
-38.46% | Details | |
| 10/30/2018 | Proteon Therapeutics | PRTO | New Coverage | Buy (N/A) |
1.60 (3.48) |
117.5% | Details | |
| 10/18/2018 | Actinium Pharma | ATNM | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2018 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2018 | Atossa Genetics | ATOS | Maintain | Buy (N/A) |
|
Details | ||
| 10/2/2018 | Aridis Pharmaceuticals | ARDS | New Coverage | Buy (N/A) |
13.06 (1.10) |
-91.58% | Details | |
| 9/25/2018 | Bionano Genomics | BNGO | New Coverage | Buy (N/A) |
6.99 (1.34) |
-80.83% | Details | |
| 9/24/2018 | Matinas BioPharma Holdings Inc. | MTNB | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2018 | Interpace Diagnostics Group Inc | IDXG | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2018 | IntelGenx Technologies Corp | IGXT | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2018 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2018 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2018 | Adamis Pharmaceuticals | ADMP | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2018 | Cytori Therapeutics, Inc. | CYTX | Downgrade | Hold (Buy) |
0.38 (0.21) |
-44.74% | Details |
